About UsInvestmentsManagementNewsContact

Current News Releases

8/21/2014: ViaCyte, Inc. ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.
PHV 8.21.2014 | link
8/19/2014: ViaCyte, Inc. ViaCyte, Inc. Announces FDA Acceptance of IND to Commence Clinical Trial of VC-01 Candidate Cell Replacement Therapy for Type 1 Diabetes.
PHV 8.19.2014 | link
7/10/2013: ViaCyte, Inc. raises $10.6 Million in a Private Financing to Support Clinical Development of its Cell Therapy Product for Insulin Dependent Diabetes.
PHV 7.10.2013 | link
2/13/2013: JDRF and California Institute for Regenerative Medicine Increase Funding of ViaCyte.
PHV 2.13.2013 | link
1/31/2013: ViaCyte's Role as a Leading Cell Therapy Company Bolstered with the Issuance of 20 Patents in 2012.
PHV 1.31.2013 | link

Archived News Releases

© Pacific Horizon Ventures, 2015.